20/20 Biolabs Inc (AIDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | |
| Cash Flows From Operating Activities | ||
| Net Income | -3,739 | -5,552 |
| Depreciation Amortization | 193 | 141 |
| Accounts receivable | -65 | -66 |
| Accounts payable and accrued liabilities | 496 | 12 |
| Other Working Capital | 837 | 620 |
| Other Operating Activity | 358 | 2,247 |
| Operating Cash Flow | $-1,920 | $-2,599 |
| Cash Flows From Investing Activities | ||
| Investing Cash Flow | $N/A | $N/A |
| Cash Flows From Financing Activities | ||
| Debt Issued | 989 | N/A |
| Common Stock Issued | 5 | N/A |
| Other Financing Activity | 168 | 293 |
| Financing Cash Flow | $1,162 | $293 |
| Beginning Cash Position | 1,784 | 4,090 |
| End Cash Position | 1,026 | 1,784 |
| Net Cash Flow | $-758 | $-2,306 |
| Free Cash Flow | ||
| Operating Cash Flow | -1,920 | -2,599 |
| Free Cash Flow | -1,920 | -2,599 |